208 related articles for article (PubMed ID: 36935926)
1.
Qureshi KA; Azam F; Fatmi MQ; Imtiaz M; Prajapati DK; Rai PK; Jaremko M; Emwas AH; Elhassan GO
PeerJ; 2023; 11():e14502. PubMed ID: 36935926
[TBL] [Abstract][Full Text] [Related]
2.
Qureshi KA; Al Nasr I; Koko WS; Khan TA; Fatmi MQ; Imtiaz M; Khan RA; Mohammed HA; Jaremko M; Emwas AH; Azam F; Bholay AD; Elhassan GO; Prajapati DK
Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438937
[TBL] [Abstract][Full Text] [Related]
3. Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X
Qureshi KA; Bholay AD; Rai PK; Mohammed HA; Khan RA; Azam F; Jaremko M; Emwas AH; Stefanowicz P; Waliczek M; Kijewska M; Ragab EA; Rehan M; Elhassan GO; Anwar MJ; Prajapati DK
Sci Rep; 2021 Jul; 11(1):14539. PubMed ID: 34267232
[TBL] [Abstract][Full Text] [Related]
4. A marine-derived Streptomyces sp. MS449 produces high yield of actinomycin X2 and actinomycin D with potent anti-tuberculosis activity.
Chen C; Song F; Wang Q; Abdel-Mageed WM; Guo H; Fu C; Hou W; Dai H; Liu X; Yang N; Xie F; Yu K; Chen R; Zhang L
Appl Microbiol Biotechnol; 2012 Aug; 95(4):919-27. PubMed ID: 22543353
[TBL] [Abstract][Full Text] [Related]
5. In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions.
Hanwarinroj C; Thongdee P; Sukchit D; Taveepanich S; Kamsri P; Punkvang A; Ketrat S; Saparpakorn P; Hannongbua S; Suttisintong K; Kittakoop P; Spencer J; Mulholland AJ; Pungpo P
J Mol Graph Model; 2022 Sep; 115():108231. PubMed ID: 35667143
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.
Freitas de Freitas T; Roth CD; Abbadi BL; Hopf FSM; Perelló MA; de Matos Czeczot A; de Souza EV; Borsoi AF; Machado P; Bizarro CV; Basso LA; Timmers LFSM
J Comput Aided Mol Des; 2023 Mar; 37(3):117-128. PubMed ID: 36547753
[TBL] [Abstract][Full Text] [Related]
7. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
Uddin R; Zahra NU; Azam SS
Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
[TBL] [Abstract][Full Text] [Related]
8. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against
Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K
Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795
[TBL] [Abstract][Full Text] [Related]
9. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of magnesium oxide and zinc oxide nanoparticles against multi-drug-resistance Mycobacterium tuberculosis.
Yaghubi Kalurazi T; Jafari A
Indian J Tuberc; 2021 Apr; 68(2):195-200. PubMed ID: 33845951
[TBL] [Abstract][Full Text] [Related]
11. A multidrug efflux protein in Mycobacterium tuberculosis; tap as a potential drug target for drug repurposing.
Dwivedi M; Mukhopadhyay S; Yadav S; Dubey KD
Comput Biol Med; 2022 Jul; 146():105607. PubMed ID: 35617724
[TBL] [Abstract][Full Text] [Related]
12. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase.
Onyenaka C; Idowu KA; Ha NP; Graviss EA; Olaleye OA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138972
[TBL] [Abstract][Full Text] [Related]
13. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus.
Sharma M; Manhas RK
BMC Microbiol; 2019 Feb; 19(1):44. PubMed ID: 30782119
[TBL] [Abstract][Full Text] [Related]
16. Fidaxomicin has high
Sun Q; Wang S; Liao X; Jiang G; Huang H; Li H; Wang G
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33593474
[TBL] [Abstract][Full Text] [Related]
17. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
18. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620
[TBL] [Abstract][Full Text] [Related]
19. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
[TBL] [Abstract][Full Text] [Related]
20. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]